Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Non Operating Income: 2009-2024

Historic Non Operating Income for RedHill Biopharma (RDHL) over the last 15 years, with Dec 2024 value amounting to $6.3 million.

  • RedHill Biopharma's Non Operating Income rose 558.85% to $47.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$8.9 million, marking a year-over-year increase of 72.05%. This contributed to the annual value of $6.3 million for FY2024, which is 43.77% down from last year.
  • As of FY2024, RedHill Biopharma's Non Operating Income stood at $6.3 million, which was down 43.77% from $11.3 million recorded in FY2023.
  • RedHill Biopharma's Non Operating Income's 5-year high stood at $12.5 million during FY2020, with a 5-year trough of -$28.8 million in FY2022.
  • Its 3-year average for Non Operating Income is -$3.7 million, with a median of $6.3 million in 2024.
  • As far as peak fluctuations go, RedHill Biopharma's Non Operating Income surged by 1,492.31% in 2020, and later slumped by 232.99% in 2021.
  • Over the past 5 years, RedHill Biopharma's Non Operating Income (Yearly) stood at $12.5 million in 2020, then crashed by 232.99% to -$16.6 million in 2021, then crashed by 73.55% to -$28.8 million in 2022, then soared by 139.15% to $11.3 million in 2023, then tumbled by 43.77% to $6.3 million in 2024.